News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Critic at Large
Critic at Large
Opinion: An Ethical Code for Conferences
Wolf B. Frommer | Dec 2, 2016
This fundamental form of scientific communication is threatened by modern recording technology and researchers who refuse to adhere to an age-old ethical code.
Opinion: Not All Genetic Databases Are Equal
Charles M. Strom | Dec 1, 2016
Sorting out which data sets are clinical-grade is key to helping patients.
Opinion: Aging, Just Another Disease
Mutaz Musa | Nov 1, 2016
No longer considered an inevitability, growing older should be and is being treated like a chronic condition.
Opinion: Fixing Science’s Human Bias
Edward Courchaine, Sarah Smaga | Sep 1, 2016
It’s time to accelerate the conversation about why the research community is still not diverse.
Opinion: Our Inner Caveman
João Pedro de Magalhães | Aug 1, 2016
The modern human brain evolved in social and environmental settings very unlike today’s. Despite our cultural and technological progress, tribal instincts remain.
The Global Science Era
Ephraim M. Govere | May 1, 2016
As international collaboration becomes increasingly common, researchers must work to limit their own biases and let cultural diversity enhance their work.
Amy K. LeBlanc, Timothy M. Fan, Nicola Mason | Apr 1, 2016
Studying tumor development and treatment in dogs and cats, in parallel with research on rodents and humans, could improve the successful translation of new cancer drugs.
Getting Animal Research Right
Andrew Jefcoat | Mar 1, 2016
Regulatory and compliance expectations for animal-based research are demanding, while public and political scrutiny of animal research is rising.
Scientific Literacy Redefined
Cynthia Brandenburg | Feb 1, 2016
Researchers could become better at engaging in public discourse by more fully considering the social and cultural contexts of their work.
The Age of Pharmabrewing
Laura Marengo and John D. Loike | Jan 1, 2016
We should not resist developing opiate-producing GM yeast for fear of the technology falling into the wrong hands.